A prospective randomised controlled mixed-methods pilot study of home monitoring in adults with cystic fibrosis
2022; SAGE Publishing; Volume: 16; Linguagem: Inglês
10.1177/17534666211070133
ISSN1753-4666
AutoresE.F. Nash, J. Choyce, Victoria Carrolan, Edwin Justice, Karen Shaw, Alice Sitch, Hema Mistry, J.L. Whitehouse,
Tópico(s)Mobile Health and mHealth Applications
ResumoHome monitoring (HM) is able to detect more pulmonary exacerbations (PEx) than routine care (RC) in individuals with cystic fibrosis (CF), but there is currently no evidence for benefits in health outcomes. Patient experiences of using HM and a health economics assessment have not been rigorously assessed to date. This study aimed to assess the effects of HM on hospital admissions, quality of life, antibiotic requirements, exacerbation frequency, lung function, nutritional outcomes, anxiety, depression, costs and health outcomes, as well as the qualitative effects on the patient experience.
Referência(s)